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EDITORIAL 
COMMENT
In 1999, the prevailing response-to-injury hypothesis of Russell 
Ross stated that atherosclerosis is an inflammatory disease, lead-
ing - through an inside-out road - to endothelial and smooth 
muscle dysfunction resulting in the formation of atherosclerotic 
plaques (reviewed in 1). Accordingly, intima-media thickness 
became an accepted measure of structural vascular remodeling 
and a strong predictor of atherosclerosis. However, it is unlikely 
that such a road may solely travel the whole multiplex network 
like that of atherogenesis. Recently things changed dramatically 
and the attention was moved from inside-out to outside-in road 
emphasizing the role for adventitial and adipose dysfunction in 
the processes of atherogenesis (2, 3).   
There are two major types of adipose tissues, white adipose 
tissue (WAT) and brown adipose tissue (BAT). Anatomically, 
WAT comprises two major depots, subcutaneous  and visceral, 
and multiple small depots around internal organs (Fig. 1). On 
the other hand BAT is localized around kidney, adrenal, pan-
creas, liver and neck, as well as the thoracic aorta (perivascular 
adipose tissue, PVAT) and the epicardium (epicardial adipose 
tissue, EAT) (4, 5). 
Two roads diverged in a wood, and I -
I took the one less traveled by,
And that has made all the difference.
Robert Frost, The Road Not Taken 
Figure 1. Schematic illustration of a large adipose depot (vis-
ceral and subcutaneous adipose tissue shown as one big cir-
cle in the middle) and small adipose depots (organ-associated 
adipose tissue shown as small circles at the periphery). Endo-
crine action (long arrows) and paracrine action (short arrows) 
of adipokines, lipokines and other adipose-derived signals on 
various organs. Organ parenchyma (grey) is surrounded by 
adipose tissue (white). From (20).
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Adipose tissue remodeling (phenotypic modulation) is a 
complex process that allow adaptation to external changes (re-
viewed in 5). A deeper understanding of this phenomenon may 
give better insights in the pathogenesis of obesity and related 
cardiometabolic diseases. And may facilitate the development of 
therapeutic modalities for them. 
The modulation of PVAT from brown/thermogenic to white/
proinflammatory phenotype is highlighted at an epigenetic level 
by Karl Blirando in his state-of-the-science (SOS) review pub-
lished in this volume of Adipobiology (6). Regarding PVAT we 
prefer the term tunica adiposa (7, 8; Fig. 2) or periadventitial 
adipose tissue (PAAT) as a path to atherogenesis (9).
diet and/or inflammation. Blirando’s SOS highlights the epige-
netic regulation of PVAT’s expression of key biomolecules in-
volved in the control of metabolism and inflammation such as 
AMP-activated protein kinase (AMPK), sirtuin 1 (SIRT1), adi-
ponectin, leptin and nerve growth factor (NGF); see Fig. 2 of (6).
According to most reports PVAT is found around vessels of 
large and medium size. In 1991, Soltis and Cassis reported for the 
first time that PVAT has an anti-contractile effect (12). Healthy 
PVAT is generally characterised by the degree of its thermogen-
ic, anti-contractile and anti-inflammatory function.  The loss of 
these properties is regarded as a dysfunction of PVAT. Whereas 
ontogeny defines PVAT localization around blood vessels, the 
main determinant of PVAT phenotype in adulthood seems to be 
the local environmental factors as illustrated in Blirando’s figure 
1A, B (6).
Today’s paradigm says that atherosclerosis mainly occurs 
in arteries surrounded by white PVAT (Fig. 3). There is not a 
clear division of pure BAT or pure WAT in both PVAT and EAT. 
Plasticity and infiltration of brown adipocytes in WAT may 
lead to the formation of brite adipose tissue (brown in white). 
Accordingly, beige or brite adipocytes are newly identified type 
of brown adipocyte distinct from the classical brown adipocyte 
that makes up the interscapular thermogenic organ of other 
mammals (4, 6, 13 for PVAT, 4, 5, 14 for EAT).
Until recently, physicians have looked upon obesity and relat-
ed diseases as an accumulation of external adipose tissue (sub-
cutaneous and abdominal). This was routinely evaluated by an-
thropometric measurements including BMI and waist, hip and, 
recently, neck circumference. However, recent data using non-
invasive imaging, such as echography, computed tomography, 
MRI and positron emission tomography, reveal a new picture of 
adipotopography. We should therefore focus our attention not 
only on anthropometric values of external adipose tissue, but 
- more importantly - the “weight” of internal, organ-associated 
adipose tissue, including PVAT/tunica adiposa. Thin outside, fat 
inside (TOFI) and other phenotypes of adipose distribution are 
based on imaging data (17) and illustrated in Table 1 herein.
Table 1. Adipotopography – variations+
TOFI**           thin outside, fat inside 
TOTI*****       thin outside, thin inside 
FOFI*            fat outside, fat inside 
FOTI***         fat outside, thin inside
+ The number of asterisks indicates quality, here – the quality of car-
diometabolic health, as related to adipose tissue distribution. TOTI 
represents a highest, whereas FOFI the lowest quality of cardiometa-
bolic health.
Figure 2. Schematic presentation of a cross-sectioned arte-
rial wall consisted of tunica intima, tunica media, tunica ad-
ventitia and tunica adiposa. Adipose dysfunction  is mediated 
by an unbalanced  secretion of pro- and anti-inflammatory 
adipokines and lipokines, also an inhibition of the release of 
adipose-derived relaxing factors (ADRF), such as NO (10) and 
H2S (11). EDRF, endothelium-derived relaxing factor. From (8).
We learn from Blirando’s SOS that many factors associated with 
epigenetic signals are pivotal for a brown-to-white transition 
and, in turn, the metabolic syndrome and atherosclerosis. A 
large number of regulators at critical genes set up specific pat-
terns of DNA methylation and  histone phosphorylation, acety-
lation and/or methylation, which act as an epigenetic code to 
modulate the correct progress of adipocyte transition form BAT 
to WAT, a process termed PVAT whitening. The latter is a sort of 
outward remodeling, a pathological process triggered by a high fat 
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Figure 3. Regional differences in periaortic perivascular adipose 
tissue (PVAT) are related to distinct functions and pathological 
complications. The differences in PVAT might also appear within 
different regions of the same vessel, as schematically illustrated 
herein. Aortic arch and thoracic aorta are surrounded by brown 
adipose tissue, whereas abdominal aorta by white adipose tis-
sue. It may be brown PVAT which makes thoracic aorta resis-
tance to high-fat feeding thus protecting the artery wall against 
atherosclerosis. Contrary, white PVAT is highly responsive to 
high-fat diet and thus being prone to the development of ath-
erosclerosis. Modified from (13). 
As we stated in 2000, it is imperative that “to further eluci-
date the vascular function, we should no longer, as hitherto, cut 
PAAT from the vascular wall, but keep it attached and in place, 
and subject to thorough examination” (2; updated in 4-6, 15, 
16, 18, 19).  And that has made some difference, paraphrasing 
Robert Frost.     
Yet, at least one question remains unanswered: could the con-
cept of PVAT/EAT whitening (4, 6, 14, 18, 19) also work in adi-
pose tissue surrounding other internal organs (Table 2).    
Table 2. Examples of adipoparacrinology of diseases. From 
(20).
(i) Epicardial adipose tissue and cardiometabolic 
diseases
(ii) Periadventitial adipose tissue (tunica adiposa) and 
atherosclerosis
(iii) Mesenteric adipose tissue and Crohn’s disease and 
ulcerative colitis
(iv) Peripancreatic adipose tissue and type 2 diabetes 
mellitus
(v) Mammary gland-associated adipose tissue and breast 
cancer
(vi) Periprostatic adipose tissue and prostate cancer
(vii) Lymph node-associated (perinodal) adipose tissue 
and HIV-associated adipose redistribution syndrome 
(HARS)
(viii) Infrapatellar fat pad (Hoffa’s fat pad) and 
osteoarthrosis
(ix) Orbital adipose tissue and thyroid-associated 
(Graves’) ophthalmopathy
(x) Subcutaneous adipose tissue and skin diseases
(xi) Parasellar region-associated adipose body and brain 
disorders (?)
(xii) Periovarian adipose tissue and ovary disorders (?)
(xiii) Epididymal adipose tissue and sexual disorders (?)
(xiv) Retromalleolar adipose tissue and Achilles tendon 
disorders (?)
(xv) Epidural adipose tissue and spinal cord disorders (?)
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